Literature DB >> 7506355

International Commission for Protection Against Environmental Mutagens and Carcinogens. Working paper no. 2. Spontaneous mutations in mammalian cells.

B W Glickman1, V A Saddi, J Curry.   

Abstract

Spontaneous or background mutation in mammals plays an important role in both medical and evolutionary contexts. However, establishing mutation frequencies or rates has not always been easy. When the field of mammalian mutagenesis was in its infancy, the word "variant" rather than "mutant" was often used because the genetic nature of the observed phenotypic alterations could not be adequately proven. Nowadays numerous target genes have been identified in which mutant frequencies can be measured, and occasionally even rates can be estimated. Indeed, the genetic basis for 'variants' now often comes from direct DNA sequencing. This review describes the most often used and best understood genetic markers for mutation research and examines their usefulness. In addition, mutational specificity is compared for several loci and the use of DNA-sequence data in determining the origins of spontaneous mutation is also discussed. An important observation is that spontaneous mutation frequencies of similarly sized genes can vary by more than an order of magnitude. Chromosomal location, the nature of the gene product and mutational specificity may offer a partial explanation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7506355     DOI: 10.1016/0027-5107(94)90319-0

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

1.  Retroviral mutation rates and A-to-G hypermutations during different stages of retroviral replication.

Authors:  T Kim; R A Mudry; C A Rexrode; V K Pathak
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

2.  Deoxyribonucleoside triphosphate pool imbalances in vivo are associated with an increased retroviral mutation rate.

Authors:  J G Julias; V K Pathak
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

3.  The antiretrovirus drug 3'-azido-3'-deoxythymidine increases the retrovirus mutation rate.

Authors:  J G Julias; T Kim; G Arnold; V K Pathak
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.